Report #2866312

Received Oct 16, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: MA
Recovered: Unknown
Vaccinated: Jan 23, 2018
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HPV9	HPV (GARDASIL 9)	MERCK & CO. INC.	1	N021571	—

Symptoms (2)

Inappropriate schedule of product administrationNo adverse event

Symptom narrative

HCP reports that the patient received their first dose of GARDASIL 9 on 01/23/2018 and has not received their second dose yet; no additional AE; This spontaneous report was received from a Pharmacist and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 23-Jan-2018, the patient started therapy with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9), (lot #N021571, expiration date: 29-Apr-2020), dose number 1, 0.5 mL as prophylaxis. It was stated by the pharmacist that the patient had not received the second dose yet (Inappropriate schedule of vaccine administered). No additional adverse event was reported.